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The last part of the 19th century was a period of great achievements in medicine and endocrinology. The thyroid gland evolved
from being considered a rudimentary structure to an organ related to speciﬁc diseases. The singular importance of iodine became
acknowledged. Graves-Basedow’s disease was described. Surgical treatment evolved with extraordinary speed. Theodor Kocher
observed that the clinical picture in patients after total thyroidectomy was similar to the one seen in cretinism. In 1850, the ﬁrst
case of hypothyroidism or myxedema was described. Less than 50 years later, eﬀective treatment was introduced. Another 50 years
later, autoimmune thyroiditis was ascertained as the most frequent cause of hypothyroidism (in areas with no iodine deﬁciency).
This paper gives a short survey of the history of hypothyroidism and its treatment.
1.Introduction
During the 50 years preceding World War I, medicine saw a
wealth of new ideas and novel procedures, not in the least
within the ﬁeld of endocrinology.
Among major achievements of this period were the rec-
ognition of the importance of the pituitary gland, ﬁrst sug-
gested by Oscar Minkowski (1858–1931) [1] and introduc-
tion of pituitary surgery [2]—not only for pituitary tumors
but also as treatment of acromegaly [3]; the delineation of
hypopituitarism as a nosological entity [4]; the discovery in
1877 (by a medical student) of the parathyroid glands [5]
andrecognitionoftheirvitalimportance [6];introductionof
thyroid surgery, pioneered by Rehn [7], Theodor Billroth [8]
and above all TheodorKocher (1841–1917)[9]; Minkowski’s
demonstration that pancreatectomy swiftly leads to severe
diabetes mellitus [10]. Halban [11]a n dK n a u e r[ 12]p e r -
formed important experiments demonstrating that chemical
substances controlling menstruations were released from the
ovary. Similarly, Reinke [13] and Bouin and Ancel [14]
proposed that testis was a gland with internal secretion—
studies that were the vanguard of an impressive number
of investigations on the relationship between the pituitary
and the gonads [15]. The ﬁrst hormone was synthesized
(adrenaline or epinephrine) by Jokichi Takamine (1854–
1922) in 1901 [16]. What was probably the supreme feat
of the epoch took place on January 16, 1902 when William
Bayliss (1860–1924) and Ernest Henry Starling (1866–1927)
for the ﬁrst time UK witnessed the eﬀect of a substance later
to be identiﬁed as a hormone (secretin) [17].
There was virtually no endocrine organ that did not
become object of intensive investigation. It became clearthat
diseasesofthethyroidglandaﬀectalargenumberofpatients.
In this paper, we brieﬂy review how knowledge of the
classical thyroid disease, then myxedema, now hypothyroid-
ism, evolved.
2.EarlyObservationsonMyxedema
In 1850, a potentially important paper was published by
ThomasBlizardCurling(1811–1888),surgeonattheLondon
Hospital [18].Two girlsfroman “idiotasylum” inLancashire
in England were described; in one—10 years of age—growth
wasseverelystuntedand “thecountenancehada markedand
very unpleasant idiotic expression (and she) had very little
power of locomotion; but could manage to walk from chair
to chair with a little assistance. She had no power of speech.”2 Journal of Thyroid Research
There was no goiter. The other girl was 6 months of age and
“was plump but had a marked idiotic expression, a large face
with a small head, and very receding forehead. The tongue
was large and protruding from the mouth”.
Both died and autopsy was performed. No trace of the
thyroid gland could be found. The author remarked: “I am
not acquainted with any case on record in which a deﬁciency
ofthethyroidglandhasbeenobservedinthehumanbody....
In countries where cretinism and bronchocele prevail, it was
long supposed, that there was some connection between the
defective condition of the brain, and the hypertrophy of
the thyroid. Pathologists have recently been inclined to view
the coincidence of these two aﬀections as accidental, or as
having no direct relation.” At that time, the term “sporadic
cretinism” was used while today the diagnosis would be
congenital hypothyroidism. But the association between the
clinicalsymptomsandthethyroidglandwasnotappreciated.
The paper was overlooked and forgotten—not mentioned
even in a British review [19].
Twenty years would pass till the publication of the next
paper on this topic [20]. Fagge, assistant physician at Guy’s
Hospital, referred to a report of a 14-year-old boy from York
County, England with obvious signs of cretinism and a large
bronchocele. The author stated that “in reality, however, this
case is the only one on record (so far as I can ascertain)
in which cretinism has occurred sporadically, in association
withgoitre.”Hepointedoutthathehimselfhadseenpatients
that diﬀered in as much as though they certainly presented
with clinical evidence of cretinism, they had no goiter. His
ﬁrst patient, an 8-year-old boy, with “idiocy with stunting
of body and cretinous type of face (?congenital); no goitre.”
The second patient was a girl characterized by “stunting
of body, with change of features a cretinous type, dating
from an attack of measles (?) at eight years of age; no
goitre; soft tumours in both supraclavicular fosse; mental
faculties unimpaired; age of patient nearly 17 years”. The
author concluded that “sporadic cretinism, instead of being
associated (like endemic cretinism) with goitre, appears to
be attended with a wasting or absence of the thyroid body”.
He also observed that in children stunted growth was typical
in “sporadic cretinism” and that “it springs up, generally
without apparent cause, in the oﬀspring of a healthy father
and mother”. Finally, he noticed that the cause of sporadic
cretinism had attracted very little attention (though “it has
been supposed in certain cases to have resulted from one or
both of the parents having been intoxicated at the time of
procreation”!).
Curling and Fagge were among the very last physicians to
use the medieval expression bronchocele for goiter.
Practically every textbook states that Wiliam Gull, Gov-
ernor ofGuy’s Hospitaland Physician-in-Ordinary to Queen
Victoria, was the ﬁrst to describe myxedema as he in 1874
described what he called a “cretinous state in the adult” [21].
Hispaperisbrief, not very informative and the thyroid gland
is hardly mentioned except the remark, “In the cretinoid
condition in adults which I have seen, the thyroid was not
enlarged.” Gull expressed his somewhat hazy views on the
disease “I believe it to be a rare form of constitutional disor-
der, without any internal visceral disease, but characterised
by great inaptitude to spontaneous exertion both of mind
and body. The deposit of fat and the changes in the skin and
connective tissues correspond to a languid condition of the
venous circulation, but without any tendency to oedema, or
any sign of cardiac defect”. It is beyond human imagination
how this paper can be constructed as the ﬁrst description
of myxedema. However, Gull had the presence of mind to
note “the state is a substantive and deﬁnitive one, no one will
doubt who has had fair opportunity of observing it”.
In 1878 Ord from St. Thomas Hospital [22] published
a paper in which he coined the term myxoedema and
published the ﬁrst photography of a patient (Figure 1). He
was able to conﬁrm the ﬁndings of Curling “the thyroid
was reduced to about a fourth of its natural size, and, being
ﬂattened against the larynx, was hardly felt during life. Its
normalstructurewas almostentirelywanting,beingreplaced
by myxoedematous inﬁltration. The absence of a thyroid
gland in cases of cretinoid idiocy is certainly curious, goitre
being very abundant in regions where cretinism is endemic.”
He gave myxoedema its name from the “jelly-like swelling
of the connective tissue. the cut surfaces yielded less ﬂuid
than their appearance would promise”. He made further
reﬂections in another paper in 1878 [23].
In all these papers cretinism, cretin, and cretinous were
the key words. None of the authors was aware of the funda-
mental causal importance of the thyroid gland.
3.TheodorKocher and VictorHorsley
At a meeting in Berlin in April 1883, Professor Theodor
Kocher of Berne read a paper on the extirpation of the
thyroid [9].Hehad becomeaware ofa peculiarpostoperative
course in one of his patients. This led him to call in for
followup as many aspossible ofthe 101 patientson whom he
had performed thyroid surgery (at that time a phenomenal
number). He immediately saw how the course signiﬁcantly
diﬀered between patients who had undergone partial and
patients after total thyroidectomy. He made the conclusion
that the symptoms present in patients in whom he had
removed the entire thyroid were unmistakably similar to
those found in patients with cretinism.
OnNovember23,1883intheClinicalSocietyofLondon,
Dr. Dawtrey Drewitt presented a patient with classical symp-
toms of hypothyroidism [24]. Somebody in the audience
remarked “that there appeared to be three conditions closely
allied to each other, and having in common either absence or
probablycompletedegenerationofthethyroidbody:namely,
cretinism, myxoedema, and the state after total removal of
the thyroid body”. At the same meeting, the ﬁrst case of
painless thyroiditis in pregnancy was brieﬂy described.
Sir Victor Horsley (1859–1916) (Figure 2) was another
outstanding ﬁgure in the ﬁeld of medicine in the last half of
the 19th century—involved in many areas of medicine and
physiology[25].Heismostrenownedasaneurosurgeon(the
ﬁrst to perform pituitary surgery) [26].
Horsley reviewed the possible function of the thyroid
gland [27]: “Up till the year 1883, the function of the thyroidJournal of Thyroid Research 3
Figure 1:First photo ofa patient with myxedema.From Ord (1878).(a) Patientat the ageof 21—before onsetofsymptoms.(b) Seven years
later. (c) Four years later.
Figure 2: Sir William Horsley (1859–1916).
gland was unknown, and considered to be of slight impor-
tance, at least to the adult animal. The theories concerning
its function were: (1) The one propounded by Mr. Simon
(in) 1844, that the thyroid body acted as a regulator of the
circulation in the brain, and possibly manufactured some
substancewhich wasofprimary importance forthenutrition
of the central nervous system. (2) That it was a true gland,
and secreted a mucinous albuminoid into the cavities of its
acini, the secretion being reabsorbed by the lymphatics. (3)
The thyroid gland has also from time to time been compared
to the spleen as a hematopoietic organ”.
He gave an account of his experience of removing the
thyroid in animals. He was in no doubt that when he
excised the thyroid, myxedema gradually developed. Horsley
speculated “the practical surgical question (is) as to whether
the cretinous symptoms following thyroidectomy are due to
(1)Chronicasphyxia, asbelievedbyKocher; (2)Injury ofthe
sympathetic and other nerve trunks (3) Arrest of function
of the thyroid gland is almost settled in favour of the third
view, and with it also the pathology of Myxoedema.” Horsley
described in detail tetany but of course could have no idea of
its cause.
In The British Medical Journal in 1885, he summed up
recent research within this ﬁeld [28]. He began by stating
“various as have been surmises as to the function of the
thyroid gland, it is not a little surprising that, although
arrest of it had been vaguely known for hundreds of years
to be connected with the cretinous state....C r e t i n i s m ,a s
is well known, has been attributed to every cause except
the destruction of the thyroid. Chalky water, damp close
air, miasma, insuﬃcient food, and so forth, and hereditary
inﬂuence, have all been credited with the power of causing
the imbecile condition which is so familiar to everyone.”
He went on stating “I am prepared, in my ﬁrst two lec-
tures, to support the dictum (ﬁrst completely enunciated by
my friend, Dr. Felix Semon) that cretinism, congenital or
acquired myxoedema, and cachexia strumipriva, are merely
p h a s e so fo n ea n dt h es a m es t a t e ,a n dd u et ot h es a m ec a u s e ,
namely, arrest ofthefunction ofthethyroid gland.”Horsley’s
reference to Felix Semon (1849–1921) is a little odd. It is
true that in the above meeting of the Clinical Society in
London 1883, it was just Semon who had in fact made this
suggestion.
However, he clearly stated that he was citing Kocher
who shortly before had presented his hallmark study on
thyroidectomy and its consequences [9]. Felix Semon was
present at this meeting—not surprising as he in fact was a
Prussian who had moved to Great Britain where he was one
of the foundersofotolaryngology—having special interest in
cancer of the larynx and not in thyroid diseases.4 Journal of Thyroid Research
4.Cretinism,EndemicGoiter,Iodine,
and Hypothyroidism
Though there is no complete agreement on the deﬁnition, it
is fair to say that at present cretinism denotes the extreme
clinical picture secondary to lack of thyroid hormone during
critical phases of development. When the condition is spo-
radic, it is typically caused by thyroid gland agenesis or
dysgenesis or defective biosynthesis of thyroid hormone.
Endemic cretinism occurs in areas where severe iodine deﬁ-
ciency is present. Such areas would characteristically also be
aﬀected by endemic goitre.
Authors in ancient Rome made reference to the common
occurrence of goiter in the Alps. Craneﬁeld, in his excellent
review [29], cites Vitruvius (c 75–c 10 BC) for the statement
“the Acquiculi in Italy and the nation of the Medulli in the
Alps have a kind of water which causes those who drink it to
have swollen throats” and Juvenal (late 1st century AD) for
“who wonders at a swollen throat in the Alps?” Curiously,
no text mentioning the neurological symptoms or mental
deﬁcits is on record.
The earliest recognition of the association between goiter
and intellectual impairment typical of cretinism may be an
illustration in a book “Reuner Musterbuch” written in 1215
at a Cistercian Abbey near Graz in present-day Austria. It
depicts an obviously imbecile person with a monstrous goi-
ter. Merke [30] found several descriptions of the occurrence
of goiter in the Pyrenees and Alps in the literature from
between 1300 and 1418, but oddly idiocy was not mentioned
here either.
Theophrastus Bombast von Hohenheim, better known
as Paracelsus (1493–1541), is often referred to as the ﬁrst to
describe the combination of goiter and cerebral and intel-
lectual deﬁciencies in 1527 [31]. However, his description is
lapidary in the extreme (“the strumeous are rarely intelli-
gent”). According to Craneﬁeld [29], a Swiss physician Felix
Platter (1536–1614) gave the ﬁrst more detailed description
ofcretinismin1602:“itisusualthatmanyinfantssuﬀerfrom
innate folly. Besides, the head is sometimes misshapen: the
tongueishugeandswollen;theyaredumb;thethroatisoften
goitrous. Thus they present an ugly sight; and sitting in the
streets and looking into the sun, and putting little sticks in
between their ﬁngers, twisting their bodies in various ways,
with their mouths agape they provoke passersby to laughter
and astonishment.”
The term “cretinism” appears ﬁrst in the French dictio-
nary (encyclop´ edie) published by Diderot in 1754. The origin
of the word cretin has been much debated—it has been
speculated that the word “cretin” developed from the Swiss-
French word crestin meaning Christian or human being, as
a reminder that these imbecile, disﬁgured, and grotesque
creatures were humans and not beasts.
After the discovery of iodine in 1811, it was soon specu-
lated that iodine might have a prophylactic eﬀect on goiter.
Coindet, a physician from Geneva, began dispensing iodine
tincture to patients with goiter, though he had no idea
of the mechanism [32]. Boussingault, a French mining
engineer (1802–1887),traveled extensively in SouthAmerica
and noticed the huge number of subjects with goiter
(and cretinism)—“the most deplorable condition seen in
mankind”. His main thesis was that goiter was instigated
by lack of oxygen in drinking water. It was common at the
high altitudes in mountains because of reduced atmospheric
pressure. Hewas, however,aware of onesubstancewhich was
infallible in treating goiter: iodine. He observed that goiter
was absent in areas where drinking water was rich in iodine
and frequent when water was iodine depleted. He also noted
thatpeoplewhosettledinaniodine-poorareawoulddevelop
goiter which disappeared when traveling to an iodine rich
region.Headvocatedtheuseofiodinatedsalt[33].Hispaper,
published in 1833, is very impressive, based on traveling in
a vast area including modern Columbia and Venezuela—
making stringent observations within chemistry, geology,
and medicine.
The French chemist Adolphe Chatin (1813–1901) was
the ﬁrst to propose that goiter might be caused by iodine
deﬁciency. He remarked “the main cause of goiter seems to
be a low concentration of iodine in the drinking water in
certain areas. Changing the water source and animal foods
and above all of eggs are rational treatments against this
condition” [34]. The German chemist Baumann cheerfully
commented on these words, “they were consigned to eternal
oblivion”.
In the 1860s, the ﬁrst trials had been conducted in three
regions of France (Departements de Bas-Rhin, Seine-Infe-
rieure, and Haute-Savoie)[35]. The administration of iodine
yielded promising results. 5000 children with goiter were
given iodine and 4000 were cured or “showed marked im-
provement”.
5.ClinicalPresentation
Even at an early time, the clinical presentation of myxedema
was well known. In the UK alone, a fair number of papers
dealt with myxedema in the 1870s and 1880s—some have
been reviewed by Doyle [19]. Many of these case reports still
make fascinating reading.
Before treatment became routine, hypothyroidism fre-
quently ran a fatal course—10 years being the typical length
of time from diagnosis to demise. It is apparent that the
hypothyroid patient seen by physicians often would appear
quite diﬀerent from the one seen today. Many patients were
not diagnosed until late in the course when severe intel-
lectual, neurological, and psychiatric deﬁciency had left the
patient in an extreme calamitous situation with dementia,
debilitating neuropathy including speaking and hearing
deﬁcits and hypothermia—symptoms seen only exception-
ally rarely today. In one patient in whom hypothyroidism
apparently had precipitated psychosis with religious delu-
sions, body temperature had fallen to 24.5◦C!
In 1989, Fulop [36] called attention to what he consid-
ered an often overlooked ﬁnding in one of his hypothyroid
patients: enlarged salivary glands. He referred to an old
Czechoslovakian paper which he thought was the ﬁrst studyJournal of Thyroid Research 5
to mention this phenomenon. However, several early publi-
cations, the ﬁrst one seems to be Horsley’s lecture in 1885
[28], pointed out that enlarged salivary glands are (or at least
at that time) were a characteristic and not infrequent ﬁnding
in myxedema.
6.CausesofHypothyroidism
So, at the end of the 19th century it was generally assumed
that hypothyroidism was brought about by hyposecretion
in the thyroid of one or more substances. A study in 1895
by Baumann in Germany (the same Baumann who had
conveyed such sanguine views on Chatin’s hypothesis on
iodine) was highly important [37]. He found a substance
(thyroiodine) rich in iodine in thyroid tissue in both animals
and man, eﬀective in treating myxedema. This ﬁnding sug-
gested that iodine somehow was crucial for thyroid function.
This made it easy to understand why iodine deﬁciency might
lead to hypothyroidism.
In 1912, a completely novel concept was introduced:
struma lymphomatosa, a thyroiditis, which for years mainly
was an anatomical designation, based on the presence of
lymphocytic inﬁltrates in the thyroid gland [38]. Within the
following years, German investigators published accountson
this disorder [39] but it attracted slight interest.
It was recognized that autoantibodies were central in
causing Graves-Basedow’s disease [40]. About the same
time, it was suggested that thyroid antibodies might also be
involvedin thedevelopmentofhypothyroidism [41,42].Not
only thyroiditis but also disorders such as diabetes mellitus
type1andAddison’sdiseasewouldprovetobeautoimmuno-
logical disorders.
While many details of the immunological response re-
main to be sorted out, there is convincing evidence that to
a large extent it is controlled by genetic factors [43]. The
role of exogenous issues—for example, iodine intake [44]
and smoking [45, 46]—has not been settled and appears
complex. Presence of lymphocytic inﬁltrates correlates with
the amount of circulating thyroid antibodies [47].
At present, the term thyroiditis has been used for a
century and the pertinent literature is exorbitant. Neverthe-
less, there is still confusion how it should be deﬁned and
subdivided. For example many use the term autoimmune
thyroiditis to cover both primary myxedema without goiter
and Hashimoto’s goiter while others suggest they are distinct
diseases. It is known that some antibodies are cytotoxic and
some block the eﬀect of thyrotropin, but exactly how these
antibodies precipitate hypothyroidism has not been settled.
Davies and Amino recently proposed a simple classiﬁca-
tion:type 1 and type2 tocoverthe diﬀerent presentations of
what many call Hashimoto’s thyroiditis while type 3 includes
Graves-Basedow’s disease [48]. Subtypes indicate whether
hyper-, hypo- or euthyroidism is present.
Untilrecently hypothyroidism was worldwide most often
caused by iodine deﬁciency [49]. Considering the many pro-
grams initiated where food supplies are fortiﬁed with iodine,
today autoimmune thyroid disease might (and certainly
ought to) be the most frequent cause of hypothyroidism.
Recent reviews have summarized the various causes of
congenital and acquired hypothyroidism [50, 51].
7.RelationshipbetweenCretinism
and Myxedema
For more than a century, distinction has been made
between a neurological “nervous” and a myxedematous
type of cretinism [52]. Mixed (or intermediate) forms are
encountered. The distribution of the forms varies according
to the endemic area. Obviously, iodine deﬁciency is a key
factor in both types. Whereas the myxedematous type as the
name implies is clinically associated with hypothyroidism
(including stunted growth and sexual immaturity), patients
with the neurological type are often euthyroid (though
frequently with goiter). Iodine given before or early in the
pregnancy will prevent the development of neurological cre-
tinism [53]. In an important study [54]f r o mC o n g o ,V a n -
derpasandcoworkersshowedthatinthemyxedematoustype
of cretinism treatment with iodine will normalize thyroid
function—providedtreatment isbegun earlyinthepostnatal
period. If not, the prognosis remains dismal.
It has puzzled researches how iodide deﬁciency ofsimilar
magnitude may lead to such clinical diversity. In a careful
and well-argued analysis of published data and their own
recent ﬁndings, Boyages and Halpern have suggested that
two events are involved in endemic cretinism [55]. One is a
transient thyroxine deﬁcit transmitted from mother to fetus
around the time of the midtrimester with neurological and
intellectual consequences. This event occurs in all cretins
whereas the second (postnatal) period of thyroid hormone
deﬁcit takes place in a subgroup only. It is the length and
severity of this second event that will decide the extent of
clinical hypothyroid symptoms present.
Though the exact cause of myxedematous cretinism is
still unclear, a wealth of skillful research has demonstrated
the importance of iodine. It is one of medicine’s major
mysteries, why it took so long for this simple message to
be transformed into straightforward measures ensuring that
populations in exposed areas are provided with iodine.
Zimmermann has recently published a superb review of
the early iodine prophylaxis [56].
8.Thyroid Hormonesand Therapy
of Hypothyroidism
In a detailed report (215 pages) delivered in 1888 by a
committee set up by the Clinical Society in London on
the relationship between cretinism, myxedema, and struma
thyropriva, the clinical symptoms are described in detail but
treatment is hardly mentioned [57].
However, a few other investigators were toiling with the
possibility of therapy and clarifying thyroid function. Thus,
the eminent German physician and physiologist Moritz
Schiﬀ (1823–1896) while working in Berne performed im-
portant experiments. He reported “thyroidectomy loses its
danger, and an essential amount of its eﬀect, if one pre-
viously introduces and ﬁxes in the abdominal cavity other6 Journal of Thyroid Research
thyroid glands from an animal of the same species” [58].
Similar grafting was performed by von Eiselberg who at
the same time transplanted thyroid and parathyroid tissue
and thus became the ﬁrst to perform parathyroid grafting
[59], though obviously he was unaware of the function of
parathyroid glands. They were discovered in 1877 [5], but
it would last almost until the end of the century before
their function was recognized [60]. Postoperative tetany
(sometimes called “acutemyxedema”) was believed to reﬂect
injury to the thyroid gland. Thyroid transplantation in man
was soon taken up by Bettencourt and Serrano in Lisbon
[61]. The eﬀect was remarkably swift and—in fact, so swift
that the authors wisely suggested that it might be due to the
absorption of the juice from healthy thyroid gland by the
tissues of the patient.
In a letter in June 1891 [62], Horsley informed George
Redmayne Murray (1865–1939) about the progress made
in various European countries as to ﬁnding treatment for
hypothyroidism. Murray at that time was a pathologist at
the Hospital for Sick Children in Newcastle. A few months
later, Murray published the ﬁrst account of a human patient
with hypothyroidism given substitution with thyroid extract
(injected subcutaneously) [63]. Clinically, the eﬀect was be-
yond doubt. The patient lived almost 30 years on thyroid
substitution—eventually to die of cardiac failure in 1919
[64].
Within months, it was discovered that oral administra-
tion of thyroid extract was eﬀective [65–67]. Fenwick [68]
noted a marked increase in diuresis after commencement of
thyroid substitution therapy.
It is evident that Murray’s achievement was not a sudden
lightning of an ingenious mind but rested on studies by
a number of investigators suggesting that the thyroid con-
tained a substance of beneﬁt in myxedema. In particular, the
contributions by Schiﬀ and Eiselberg were fundamental—as
were of cause the experiments by Murray’s mentor, Horsley.
Naturally, the central question as far as thyroid extract
was concerned,was which substancewas responsible.Impor-
tant clues were Baumann’s study in 1895 and the ﬁnding in
1907 by Marine [69] that iodine was necessary for proper
function of the thyroid gland. Magnus-Levy demonstrated
the important fact that desiccated thyroid and iodothyrin
increase oxygen consumption and output of carbon dioxide
[70].
A vivid description has been given of what a physician
might encounter at that time [71]. Around 1892, an Irish
general practitioner was asked to see a lady who obviously
was dying, her family being aware no treatment was possible.
The diagnosis was clinicallyobvious. The GP had justread in
the British Medical Journal about the proposed treatment of
myxedema and straight away gothold ofthyroid glands from
sheep. Following the instructions in the papers, he prepared
a substance which was administered to the patient who
stunned everybody by a swift and complete, almost biblical,
recovery.Incidentally,thephysicianlatergained further fame
b yo p e r a t i n go na no l da n dd e s t i t u t ew o m a no nh i sk i t c h e n
table, curing her cataract.
In 1896, Murray—not without a little pride—summed
up the present state of treatment of hypothyroidism [72].
He aﬃrmed “myxedema is a symptom or combination of
symptoms of loss of the function of the thyroid gland. In the
idiopathic form it is a symptom of chronic interstitial thy-
roiditis,justasanasarca maybeasymptomofrenaldiseaseor
ascites of hepatic disease. Thus the myxedema can be cured,
although the chronic interstitial thyroiditis still remains.”
This statement, regarding a disease that only a few years be-
foreoftenwasfatalandthecauseofwhich10yearspreviously
remained nebulous,iscertainlytestimony ofanexceptionally
dynamic period in medical science.
In 1914 on Christmas day, at the Mayo Clinic, Edward
Calvin Kendall (1886–1972) crystallized a substance—later
to be named thyroxine—containing 65.3% iodine [73].
When he repeated the procedure, he failed to isolate any
crystals. It would take 15 frustrating months ﬁnally to get
the procedure right. Eventually, 33g of crystalline substance
was obtained [74]. This allowed studies on its physiological
properties.
Perhaps because of the war, thyroxine was not chemically
identiﬁed until 1927 [75]. About 25 years later, Gross and
Pitt-Rivers [76] detected the second thyroid hormone—trii-
odothyronine,which atthesametimealso wasdemonstrated
by French investigators [77, 78].
Almost as if they were introducing a completely new
drug, Hart and Maclagan in 1950 [79]r e v i e w e dt h eu s e
of thyroxine (and particularly L-thyroxine). Actually, it had
beenavailablesincethe1930sbuthadnotgainedwideaccep-
tance (maybe because of its high cost)—despite its obvious
advantages. Desiccated thyroid was much used for many
years and as late as 1978 leading British endocrinologists
felt compelled to warn against its use [80]. It is still being
marketed (and hence probably used) in some countries—for
example, USA.
9.Organotherapy
Modern medicine developed the concept of organotherapy
in the latter part of the 19th century—advanced in particular
byan extraordinary ﬁgure:Charles-Edouard Brown-S´ equard
(1817-1894) [81]. He had advocated the use of extracts from
ovaries and testes—many of his theses were based on
excellent resultsinexperiments hehad performed onhimself
[82, 83]. In some respects, his theories would lead medicine
into an abyss of eeriness and utter bewilderment, but in
other instances it would precipitate important progress in
endocrine therapy. There can be little doubt that the beneﬁt
of thyroid substitution was a major support for the sound-
ness of organotherapy. A veritable industry grew up and ex-
tracts from a variety of organs including brain and spinal
cord were marketed and widely used (Figures 3(a)–3(c)).
Organotherapy could claim some other successes.
Around 1890 Vassale in Italy [84]a n dG l e y[ 85]i nF r a n c e
had injected thyroidectomized dogs with extract of thyroid
glands from sheep. There was an excellent eﬀect on postop-
erative tetany (which they ascribed to thyroid insuﬃciency).
1908 McCallum eﬀectively treated postoperative tetany with
an extract known to be of parathyroid origin [86]. In 1913,
two reports, one from Germany [87] and one from ItalyJournal of Thyroid Research 7
(a) (b)
(c)
Figure 3: Advertisements for organotherapeutical remedies.8 Journal of Thyroid Research
[88], demonstrated the swift and unquestionable eﬀect of
extract of the posterior lobe of the hypophysis on polyuria
in diabetes insipidus.
Only few years after Minkowski’s demonstration of the
association between pancreatectomy and diabetes mellitus,
organotherapy was also introduced as therapy for diabetes
mellitus [89]. Patients were made devour a whole pancreatic
gland per day. The results, however, were dismal. Pancreatic
transplantation was attempted, ﬁrst in 1893 [90], but proved
an utter disaster.
As an illustration of the belief in organotherapy (though
not necessarily involving the thyroid), an interesting piece
of evidence is provided by a short novel (The Creeping
Man) [91] written by Sir Conan Doyle (1859–1930)—
a physician by education. Brieﬂy, the story deals with a
professor who at a somewhat advanced age plans to marry a
much younger (and pretty) woman. To some consternation
ofhis familymembers andassociates,his behaviorundergoes
a distinct change. He starts to climb walls, walk on all
four and in general behave like an animal. His faithful dog
begins to attack him. Sherlock Holmes solves the puzzle by
demonstrating that the professor had begun treating himself
with extract from (testicular?) tissue from monkeys. Today,
this plot will appear queer, almost meaningless.
Tam [92] has given an excellent account of thyroid
organotherapy in Britain. Desiccated thyroid was prescribed
for a large number of ailments—thus obesity, various skin
diseases, asthma, and an array of gynecological diseases “the
stimulating action of the thyroid on the ovaries has been
used to good advantage in the treatment of ovarian insuf-
ﬁciency with its various manifestations—for example, infan-
tilism, amenorrhea, scanty menstruation, sterility....I tisnot
possible to explain the broad inﬂuence of thyroid medica-
tion upon this class of disease: it is far too complex”, and
curious and ill-deﬁned conditions called “toxemias.” As late
as just before World War II, a book (Walker G. The status of
enzymes and hormones in therapy. Edinburgh, John Wright
& Sons Ltd., 1935) was published reviewing the numerous
indications for organotherapy. It concluded “thyroid is
indicated in any condition in which there is depressed me-
tabolism,and henceits rangeofutilityextendsfrom anorexia
nervosa to ulcersofthe leg.” The whole organotherapy circus
would go on until Word War II when ﬁnally this appalling
chapter of the medical profession ﬁnally would be brought
to a stop [15].
10.Conclusion
Careful study of the history of hypothyroidism reveals
that investigators not widely known have in fact played a
crucial role in the development of our knowledge of thyroid
insuﬃciency. Thus, today probably only few are acquainted
with Felix Platter who gave the ﬁrst description of cretinism,
with Curling who described patients with myxedema in
1850, and perhaps even with Chatin who was the ﬁrst to
suggest the signiﬁcance of iodine in thyroid pathology. On
the other hand, the immense importance of Kocher and
Horsley in the last half of the 19th century is well known.
At this time, Murray successfully introduced treatment with
thyroid extract in hypothyroidism. In France, an apparently
adequate prophylaxis for one of mankind’s major scourges;
cretinismwaslaunchedatanearly time.Thispolicywassoon
discontinued. The reason why this practice was terminated is
not entirely clear. As early as around 1820 Coindet and Ma-
gendie had noted that the administration of iodine might
cause symptoms of hyperthyroidism (Kocher’s “Jod-Based-
ow”). For more than a century, the safety of iodine pro-
phylaxis was heatedly discussed until it was realized that the
purpose of iodine prophylaxis ideally should be to ensure a
suﬃcientiodineintake[93].Problemswouldappearifiodine
was given in supraphysiological amounts [94].
So within less than 50 years, hypothyroidism was recog-
nized,andeﬀectivetreatmentwasmadeavailable.Prevention
of the most frequent type of hypothyroidism was docu-
mented, and preventive intervention had in fact been insti-
tuted. However, partly because the medical establishment
and health authorities showed little concern, early initiatives
were abandonedcausing muchmisery togenerationsinlarge
parts of the world.
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